CLPT
ClearPoint Neuro, Inc.NASDAQHealthcare$9.37+2.52%ClosedMarket Cap: $278.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
9.48
P/S
7.55
EV/EBITDA
-13.00
DCF Value
$-16.08
FCF Yield
-8.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.4%
Operating Margin
-65.4%
Net Margin
-69.1%
ROE
-122.2%
ROA
-26.1%
ROIC
-27.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $10.4M | 61.5% | $-7.0M | $-7.8M | $-0.27 | — |
| FY 2025 | $37.0M | 61.4% | $-24.2M | $-25.5M | $-0.90 | — |
| Q3 2025 | $8.9M | 63.2% | $-5.3M | $-5.9M | $-0.21 | — |
| Q2 2025 | $9.2M | 60.3% | $-5.7M | $-5.8M | $-0.21 | — |
| Q1 2025 | $8.5M | 60.5% | $-6.2M | $-6.0M | $-0.22 | — |
| Q4 2024 | $7.8M | 61.3% | $-5.6M | $-5.4M | $-0.20 | — |
| FY 2024 | $31.4M | 60.9% | $-19.7M | $-18.9M | $-0.70 | — |
| Q3 2024 | $8.1M | 59.7% | $-5.2M | $-5.0M | $-0.18 | — |
| Q2 2024 | $7.9M | 63.5% | $-4.7M | $-4.4M | $-0.16 | — |
| Q1 2024 | $7.6M | 59.2% | $-4.2M | $-4.1M | $-0.16 | — |
| Q4 2023 | $6.8M | 58.9% | $-4.7M | $-4.6M | $-0.19 | — |
| FY 2023 | $24.0M | 56.8% | $-22.4M | $-22.1M | $-0.90 | — |